News
Mitoxantrone Versus Liposomal Daunorubicin in Induction of Pediatric AML With Risk Stratification Based on Flow Cytometry Measurement of Residual Disease For prediction of deleterious TP53 mutations, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback